Affordable Access

Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin.

Authors
  • Steluti, Regilene
  • De Rosa, Fernanda Scarmato
  • Collett, John
  • Tedesco, Antônio Cláudio
  • Bentley, Maria Vitória Lopes Badra
Type
Published Article
Journal
European Journal of Pharmaceutics and Biopharmaceutics
Publisher
Elsevier
Publication Date
Aug 01, 2005
Volume
60
Issue
3
Pages
439–444
Identifiers
PMID: 15996585
Source
Medline
License
Unknown

Abstract

Photodynamic therapy (PDT), a potential therapy for cancer treatment, utilizes exogenously applied or endogenously formed photosensitizers, further activated by light in an appropriate wavelength and dose to induce cell death through free radical formation. 5-Aminolevulinic acid (5-ALA) is a pro-drug which can be converted to the effective photosensitizer, protoporphyrin IX (PpIX). However, the use of 5-ALA in PDT is limited by the low penetration capacity of this highly hydrophilic molecule into appropriate skin layers. In the present study, we propose to increase 5-ALA penetration by using formulations containing glycerol monooleate (GMO), an interesting and useful component of pharmaceutical formulations. Propylene glycol solutions containing different concentrations of GMO significantly increased the in vitro skin permeation/retention of 5-ALA in comparison to control solutions. In vivo studies also showed increased PpIX accumulation in mouse hairless skin, after the use of topical 5-ALA formulations containing GMO in a concentration-dependent manner. The results show that skin 5-ALA penetration and PpIX accumulation, important factors for the success of topical 5-ALA-PDT in skin cancer, are optimized by GMO/propylene glycol formulations.

Report this publication

Statistics

Seen <100 times